These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 12407728)
1. Quantitative analysis of heparanase messenger RNA expression in hepatocellular carcinoma. Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N J Surg Oncol; 2002 Nov; 81(3):148-54; disscusion 154. PubMed ID: 12407728 [TBL] [Abstract][Full Text] [Related]
2. [Expression of heparanase mRNA and its clinical significance in primary hepatocellular carcinoma]. Zhang YL; Fu ZR; Ding GS; Fu H; Wang YH; Wang Q Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):359-61. PubMed ID: 12921566 [TBL] [Abstract][Full Text] [Related]
3. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma]. Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066 [TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. Ikeguchi M; Hirooka Y; Kaibara N Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288 [TBL] [Abstract][Full Text] [Related]
5. The expression of Heparanase mRNA and its clinical significance in Hepatocellular carcinoma. Wang Q; Shen Y; Wang P; Li X J Cancer Res Ther; 2013; 9(2):250-2. PubMed ID: 23771368 [TBL] [Abstract][Full Text] [Related]
6. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma. Ikeguchi M; Iwamoto A; Taniguchi K; Katano K; Hirooka Y J Exp Clin Cancer Res; 2005 Sep; 24(3):415-21. PubMed ID: 16270528 [TBL] [Abstract][Full Text] [Related]
7. The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma. El-Assal ON; Yamanoi A; Ono T; Kohno H; Nagasue N Clin Cancer Res; 2001 May; 7(5):1299-305. PubMed ID: 11350898 [TBL] [Abstract][Full Text] [Related]
8. Involvement of RhoA in progression of human hepatocellular carcinoma. Wang D; Dou K; Xiang H; Song Z; Zhao Q; Chen Y; Li Y J Gastroenterol Hepatol; 2007 Nov; 22(11):1916-20. PubMed ID: 17914970 [TBL] [Abstract][Full Text] [Related]
9. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma]. Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766 [TBL] [Abstract][Full Text] [Related]
10. Detection of peritoneal micrometastasis by reverse transcriptase-polymerase chain reaction for heparanase mRNA and cytology in peritoneal wash samples. Wang Z; Zhang X; Xu H; Zhou X; Jiang L; Lu C J Surg Oncol; 2005 May; 90(2):59-65. PubMed ID: 15844185 [TBL] [Abstract][Full Text] [Related]
11. Gene and protein expression of RCAS1 in hepatocellular carcinoma. Ikeguchi M; Hirooka Y; Kaibara N Anticancer Res; 2003; 23(6D):4967-71. PubMed ID: 14981953 [TBL] [Abstract][Full Text] [Related]
12. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma. Morinaga S; Nakamura Y; Ishiwa N; Yoshikawa T; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S Oncol Rep; 2004 Dec; 12(6):1189-94. PubMed ID: 15547736 [TBL] [Abstract][Full Text] [Related]
13. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis. Sato T; Yamaguchi A; Goi T; Hirono Y; Takeuchi K; Katayama K; Matsukawa S J Surg Oncol; 2004 Sep; 87(4):174-81. PubMed ID: 15334632 [TBL] [Abstract][Full Text] [Related]
14. Detection of a unique gamma-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma in humans: a new candidate for early diagnosis of hepatocellular carcinoma. Tsutsumi M; Sakamuro D; Takada A; Zang SC; Furukawa T; Taniguchi N Hepatology; 1996 May; 23(5):1093-7. PubMed ID: 8621139 [TBL] [Abstract][Full Text] [Related]
15. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis. Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643 [TBL] [Abstract][Full Text] [Related]
16. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis. Sasaki A; Ishikawa K; Haraguchi N; Inoue H; Ishio T; Shibata K; Ohta M; Kitano S; Mori M Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907 [TBL] [Abstract][Full Text] [Related]
17. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients]. Zhou Q; Liang LJ; Peng BG; Zhen YY Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916 [TBL] [Abstract][Full Text] [Related]
18. Perioperative change in albumin messenger RNA levels in patients with hepatocellular carcinoma. Gion T; Taketomi A; Shimada M; Shirabe K; Hasegawa H; Takenaka K; Sugimachi K Hepatology; 1998 Dec; 28(6):1663-8. PubMed ID: 9828232 [TBL] [Abstract][Full Text] [Related]
19. [Expression of NET-1 gene and protein in hepatocellular carcinoma and related tissues]. Chen L; Shen AG; Wang GL; Lu P; Li XY Ai Zheng; 2006 Mar; 25(3):320-5. PubMed ID: 16536986 [TBL] [Abstract][Full Text] [Related]
20. Heparanase messenger RNA expression in epithelial ovarian tumor. Kodama J; Shinyo Y; Hashen G; Hongo A; Yoshinouchi M; Hiramatsu Y Int J Mol Med; 2003 Dec; 12(6):961-4. PubMed ID: 14612974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]